Houston, Texas
Phase 1 colorectal cancer trials in Houston, TX
86 Phase 1 colorectal cancer studies are recruiting participants at sites in Houston as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Houston at a glance
- 86 studies are recruiting at a site in Houston.
- By phase: Early Phase 1 (2), Phase 1 (45), Phase 1/2 (39).
- By sponsor: industry (73), university, hospital or other (12), government (1).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in Houston
Basic details from each study's public record (the 30 most recently updated of 86). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT03594630 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT05786924 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- MD Anderson Cancer Center - University of Texas
- Registry record
- NCT06253871 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- University of Texas MD Anderson Cancer Center
- Registry record
- NCT06444815 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07020117 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study sites
- The Methodist Hospital Research Institute · The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06324357 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT06983743 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Next Oncology - Houston
- Registry record
- NCT07488676 · updated
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- SOTIO Biotech a.s.
- Study site
- NEXT Houston
- Registry record
- NCT07693751 · updated
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- M D Anderson Cancer Center
- Registry record
- NCT05195710 · updated
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Vividion Therapeutics, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT06004245 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study sites
- NEXT Houston · University of Texas MD Anderson Cancer Center
- Registry record
- NCT06270706 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- The University of Texas MD Anderson Cancer Center
- Registry record
- NCT07458347 · updated
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07500298 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07020221 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study sites
- MD Anderson · NEXT Texas LLC - Houston
- Registry record
- NCT07503808 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UT MD Anderson Cancer Center
- Registry record
- NCT06102902 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- The University of Texas - M.D. Anderson Cancer Center · The University of Texas, MD Anderson Cancer Center - West Houston
- Registry record
- NCT07318805 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The University of Texas - MD Anderson Cancer Center
- Registry record
- NCT06400472 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07114601 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07397338 · updated
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT05379595 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07416552 · updated
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Immunome, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07578571 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Oncology Consultants
- Registry record
- NCT03526835 · updated
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- MD Anderson Cancer Center
- Registry record
- NCT07887971 · updated
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Eikon Therapeutics
- Study site
- University of Texas MD Anderson Cancer Center
- Registry record
- NCT07262619 · updated
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Texas MD Anderson Cancer Center ( Site 0316)
- Registry record
- NCT06428409 · updated
A Study of MGC026 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study sites
- The University of Texas MD Anderson Cancer Center · University of Texas Health Science Center at Houston
- Registry record
- NCT06242470 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Houston, TX on ClinicalTrials.gov.
Ask about studies near Houston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
119 studies recruiting across 18 cities.
San Antonio
43 studies recruiting.
Dallas
30 studies recruiting.
Irving
15 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections